EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
EDAP TMS SA (Nasdaq: EDAP), a leader in robotic energy-based therapies, has scheduled its third quarter 2024 financial results release for November 7, 2024, before market open. The company will host a conference call and webcast at 8:30 AM EDT on the same day. CEO Ryan Rhodes, CFO Ken Mobeck, and CAO François Dietsch will lead the discussion. The conference call will be accessible via domestic (1-800-445-7795) and international (1-785-424-1699) dial-in numbers using passcode EDAP.
EDAP TMS SA (Nasdaq: EDAP), leader nelle terapie robotiche basate sull'energia, ha programmato il rilascio dei suoi risultati finanziari del terzo trimestre 2024 per il 7 novembre 2024, prima dell'apertura del mercato. La società ospiterà una teleconferenza e una trasmissione web alle 8:30 AM EDT lo stesso giorno. Il CEO Ryan Rhodes, il CFO Ken Mobeck e il CAO François Dietsch guideranno la discussione. La teleconferenza sarà accessibile tramite numeri di telefono domestici (1-800-445-7795) e internazionali (1-785-424-1699) utilizzando il codice di accesso EDAP.
EDAP TMS SA (Nasdaq: EDAP), líder en terapias robóticas basadas en energía, ha programado la publicación de sus resultados financieros del tercer trimestre de 2024 para el 7 de noviembre de 2024, antes de la apertura del mercado. La compañía llevará a cabo una conferencia telefónica y una transmisión web a las 8:30 AM EDT el mismo día. El CEO Ryan Rhodes, el CFO Ken Mobeck y el CAO François Dietsch liderarán la discusión. La conferencia telefónica será accesible a través de números de marcación nacionales (1-800-445-7795) e internacionales (1-785-424-1699) utilizando el código de acceso EDAP.
EDAP TMS SA (Nasdaq: EDAP)는 로봇 에너지 기반 치료의 선두주자로서, 2024년 3분기 재무 결과 발표를 2024년 11월 7일, 시장 개장 전에 예정하고 있습니다. 회사는 같은 날 오전 8시 30분 EDT에 컨퍼런스 콜 및 웹캐스트를 개최할 예정입니다. CEO 라이언 로즈, CFO 켄 모벡 및 CAO 프랑수아 디트쉬가 논의를 이끌 것입니다. 컨퍼런스 콜은 국내 전화 (1-800-445-7795) 및 국제 전화 (1-785-424-1699) 번호를 통해 EDAP 비밀번호를 사용하여 접근할 수 있습니다.
EDAP TMS SA (Nasdaq: EDAP), leader dans le domaine des thérapies robotiques basées sur l'énergie, a programmé la publication de ses résultats financiers du troisième trimestre 2024 pour le 7 novembre 2024, avant l'ouverture du marché. La société organisera une conférence téléphonique et un webinaire à 8h30 EDT le même jour. Le PDG Ryan Rhodes, le CFO Ken Mobeck et le CAO François Dietsch dirigeront la discussion. La conférence téléphonique sera accessible via les numéros nationaux (1-800-445-7795) et internationaux (1-785-424-1699) en utilisant le code d'accès EDAP.
EDAP TMS SA (Nasdaq: EDAP), ein führendes Unternehmen im Bereich robotergestützte energiebasierte Therapien, hat die Veröffentlichung seiner Finanzergebnisse für das dritte Quartal 2024 für den 7. November 2024, vor Marktbeginn, angesetzt. Das Unternehmen wird am selben Tag um 8:30 Uhr EDT eine Telefonkonferenz und ein Webcast veranstalten. CEO Ryan Rhodes, CFO Ken Mobeck und CAO François Dietsch werden die Diskussion leiten. Die Telefonkonferenz ist über nationale (1-800-445-7795) und internationale (1-785-424-1699) Einwahlnummern mit dem Zugangscode EDAP verfügbar.
- None.
- None.
Company to host conference call and webcast on Thursday, November 7th at 8:30am EDT
LYON, France, October 24, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the third quarter ended September 30, 2024, before the markets open on Thursday, November 7th, 2024.
An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration.
Call Details:
Date: Thursday, November 7th
Time: 8:30 am EDT
Domestic: 1-800-445-7795
International: 1-785-424-1699
Passcode: EDAP
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1691338&tp_key=a13da04d10
About EDAP TMS SA
A recognized leader in the global therapeutic ultrasound market. EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, us.hifu-prostate.com and www.focalone.com.
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
FAQ
When will EDAP (NASDAQ: EDAP) release its Q3 2024 financial results?
What time is EDAP's Q3 2024 earnings conference call?
Who will be presenting at EDAP's Q3 2024 earnings call?
